Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Renal clearable catalytic gold nanoclusters for in vivo disease monitoring

Renal clearable catalytic gold nanoclusters for in vivo disease monitoring

Thumbnail Image
Download
Name

nihms-1062497.pdf

Description
Accepted version
Size

1.83 MB

Format

Adobe PDF

Checksum (MD5)

12a039c91fd3f03e89fc7c2b908a78bb

sword-2020-12-02T17:30:57.original.xml (130 B)
Original SWORD entry document
Author(s)
Loynachan, Colleen N.
•
Soleimany, Ava P.
•
Dudani, Jaideep Sunil
•
Lin, Yiyang
•
Najer, Adrian
•
Bekdemir, Ahmet
•
Chen, Qu
•
Bhatia, Sangeeta N
•
Stevens, Molly M.
Date Issued
September 2019
Journal
Nature Nanotechnology
Publisher
Springer Science and Business Media LLC
Citation
Loynachan, Colleen N. et al. "Renal clearable catalytic gold nanoclusters for in vivo disease monitoring." Nature Nanotechnology 14, 9 (September 2019): 883–890 © 2019 The Author(s).
Version
Author's final manuscript
Abstract
Ultrasmall gold nanoclusters (AuNCs) have emerged as agile probes for in vivo imaging, as they exhibit exceptional tumour accumulation and efficient renal clearance properties. However, their intrinsic catalytic activity, which can enable an increased detection sensitivity, has yet to be explored for in vivo sensing. By exploiting the peroxidase-mimicking activity of AuNCs and the precise nanometre-size filtration of the kidney, we designed multifunctional protease nanosensors that respond to disease microenvironments to produce a direct colorimetric urinary readout of the disease state in less than one hour. We monitored the catalytic activity of AuNCs in the collected urine of a mouse model of colorectal cancer in which tumour-bearing mice showed a 13-fold increase in colorimetric signal compared to healthy mice. The nanosensors were eliminated completely through hepatic and renal excretion within four weeks of injection with no evidence of toxicity. We envision that this modular approach will enable the rapid detection of a diverse range of diseases by exploiting their specific enzymatic signatures.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
https://hdl.handle.net/1721.1/128729
DOI of Published Version
https://doi.org/10.1038/s41565-019-0527-6
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.